GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 7.023
NA - Nord America 6.476
AS - Asia 2.985
AF - Africa 99
SA - Sud America 95
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.742
Nazione #
US - Stati Uniti d'America 6.419
GB - Regno Unito 1.818
IT - Italia 1.521
CN - Cina 1.500
SG - Singapore 1.091
RU - Federazione Russa 773
IE - Irlanda 635
FR - Francia 575
SE - Svezia 540
DE - Germania 391
FI - Finlandia 382
UA - Ucraina 119
ID - Indonesia 83
TG - Togo 72
BR - Brasile 71
TR - Turchia 69
NL - Olanda 59
AU - Australia 53
ES - Italia 40
HK - Hong Kong 40
CA - Canada 36
JP - Giappone 36
IN - India 35
BE - Belgio 28
KR - Corea 24
IR - Iran 23
CH - Svizzera 21
PL - Polonia 19
MX - Messico 18
CZ - Repubblica Ceca 14
MY - Malesia 13
DK - Danimarca 12
SA - Arabia Saudita 12
AT - Austria 11
CL - Cile 11
EG - Egitto 9
PH - Filippine 8
RO - Romania 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
TH - Thailandia 7
VN - Vietnam 7
DZ - Algeria 6
HR - Croazia 6
IL - Israele 6
HU - Ungheria 5
IS - Islanda 5
LT - Lituania 5
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
LK - Sri Lanka 4
MA - Marocco 4
AL - Albania 3
AR - Argentina 3
BG - Bulgaria 3
BO - Bolivia 3
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
JO - Giordania 3
LV - Lettonia 3
NO - Norvegia 3
PK - Pakistan 3
UZ - Uzbekistan 3
AM - Armenia 2
LU - Lussemburgo 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
BZ - Belize 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 16.742
Città #
Southend 1.591
Chandler 1.055
Jacksonville 952
Singapore 888
Dublin 624
Woodbridge 551
Ashburn 446
Ann Arbor 431
Houston 428
Beijing 247
Wilmington 220
Lawrence 215
Princeton 215
Jinan 134
Nanjing 130
Milan 117
New York 114
Helsinki 100
Shenyang 100
Sindelfingen 93
Verona 87
Rome 86
Jakarta 74
Lomé 72
Hebei 63
Haikou 54
Tianjin 50
Changsha 48
Washington 48
Seattle 45
Guangzhou 44
Moscow 44
Nanchang 44
Redwood City 42
Santa Clara 42
Hangzhou 36
Zhengzhou 34
Bologna 33
Dallas 33
Hong Kong 33
Jiaxing 32
Boardman 31
Falls Church 29
Kent 29
Los Angeles 28
Ningbo 28
Brussels 27
Chicago 27
Redmond 27
Amsterdam 26
Esslingen am Neckar 25
Turin 25
Venice 23
Fairfield 22
Lappeenranta 22
Taizhou 22
Norwalk 21
Florence 19
London 19
Seoul 19
Genoa 18
Parma 18
Sydney 18
Düsseldorf 17
Shanghai 17
Dongguan 16
Lancaster 16
Frankfurt am Main 15
Fuzhou 15
Naples 15
Tokyo 14
Toronto 14
Kuala Lumpur 13
Taiyuan 13
Enfield 12
Madrid 12
Atlanta 11
Bari 11
Brescia 11
Palermo 11
Phoenix 11
Vicenza 11
Pescara 10
Catania 9
Edinburgh 9
Lanzhou 9
Perth 9
San Jose 9
Trieste 9
Vienna 9
Canberra 8
Mersin 8
Modena 8
Mumbai 8
Warsaw 8
Zurich 8
Almaty 7
Cagliari 7
Copenhagen 7
Falkenstein 7
Totale 10.622
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 590
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 331
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 316
Dietary supplements for lipedema 212
Il ruolo della vitamina D nella dermatite atopica 155
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 110
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 110
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 110
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 109
Polymorphisms, diet and nutrigenomics 106
Impact of TNF-α antagonists on the quality of life in selected skin diseases 106
Squamous cell carcinoma arising in lupus vulgaris. 105
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 105
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 104
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 103
Vitamin D levels in patients with psoriasis with or without arthritis 102
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 101
Severe impairment of quality of life in Hailey-Hailey disease. 101
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 99
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 97
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 95
Retention rate of systemic drugs in patients with chronic plaque psoriasis 94
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 93
Lebbra lepromatosa. 90
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 89
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 89
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 89
Psoriasis, the liver, and the gastrointestinal tract 88
Heat urticaria: a revision of published cases with an update on classification and management 88
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 87
The expectations of patients with psoriasis during an office consultation 87
Psoriasis and the metabolic syndrome 87
Advanced Glycation End Products in the Pathogenesis of Psoriasis 86
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 85
Targeting TNF-a in psoriasis and psoriatic arthritis. 85
Incidence of respiratory and allergic symptoms in Italian and immigrant children 85
Attitude to treatment of patients with psoriasis attending SPA center 85
Psoriasi. Una guida per una migliore gestione del paziente. 84
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 84
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 84
Pimecrolimus in dermatology: atopic dermatitis and beyond. 83
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 83
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 82
The metabolic syndrome in psoriasis 82
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 81
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 81
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 81
Acneiform eruption induced by cetuximab 80
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 80
Image Gallery: Pyoderma gangrenosum of the penis. 80
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 80
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 78
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 78
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 78
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 78
Impact of the COVID-19 pandemic on melanoma diagnosis 78
The diagnostic and therapeutic challenge of early psoriatic arthritis 78
The importance of treating mild atopic dermatitis. 77
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 77
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 77
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 76
Complicanze dell'obesità: la cute 76
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 76
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 76
Microcircolatory modifications of psoriatic lesions during topical therapy. 75
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 75
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 75
Hyperuricaemia in patients with chronic plaque psoriasis. 75
Effects of secukinumab on serum adipocytokines: preliminary data 74
Chronic plaque psoriasis is associated with increased arterial stiffness 73
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 73
PSORIASIS 73
Dermatite atopica. 72
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 72
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 72
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 71
L’organo pelle: struttura, biologia, funzioni. 71
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 71
Vitamin D status in patients with chronic plaque psoriasis 70
Autoimmune progesterone dermatitis. 69
Psodisk, a new visual method for assessing the burden of psoriasis on patients. 69
Metabolic comorbidities and psoriasis. 69
Systemic therapy of psoriasis in diabetic patients 69
Targeting tumor necrosis factor a in the therapy of psoriasis. 69
Biologic therapies in psoriasis: a new therapeutic approach 69
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 68
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 68
Usefulness of the Framingham risk score in patients with chronic psoriasis 67
Le malattie della mucosa orale 67
Concept of Remission in Chronic Plaque Psoriasis 67
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 67
Aggiornamento sulla terapie biologiche della psoriasi 66
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. 66
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 66
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 65
La dermatite atopica. 64
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 64
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. 64
La dermatite atopica nella seconda infanzia ed adolescenza 64
Considerations for Systemic Treatment of Psoriasis in Obese Patients 64
Totale 9.315
Categoria #
all - tutte 69.684
article - articoli 67.290
book - libri 260
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.134
Totale 139.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020966 0 0 0 0 0 206 142 98 104 147 98 171
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20252.605 386 349 230 1.037 360 243 0 0 0 0 0 0
Totale 17.079